Literature DB >> 27112161

Characterization of embryonic stem cell model of polycystic ovary syndrome.

Yue Zhang1,2, Yun-Shan Zhang2, Feng-Xia Xue3.   

Abstract

The aims of this study are to establish an embryonic stem (ES) cell model of polycystic ovary syndrome and to characterize this ES cell line. ES cells were isolated and cultured from 322 wasted fertilized embryos from polycystic ovary syndrome (PCOS) patients in vitro. They were also characterized by development and differential markers. ES cells from PCOS subject present normal development profile with ES-specific markers such as OCT-4 and SSEA-4. These ES cells can also differentiate into three germ layer derivatives and form teratomas in vivo. ES cells from PCOS patients pose development and differentiation potentials as you would expect of cells from non-PCOS patients; therefore, they can be used as a cellular model to study the pathology of PCOS.

Entities:  

Keywords:  Differentiation; Phenotype; Polycystic ovary syndrome; Stem cell

Mesh:

Year:  2016        PMID: 27112161     DOI: 10.1007/s11626-016-0040-2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  15 in total

1.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture.

Authors:  Jonathan S Draper; Christine Pigott; James A Thomson; Peter W Andrews
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

Review 2.  Persistent estrus rat models of polycystic ovary disease: an update.

Authors:  Krishna B Singh
Journal:  Fertil Steril       Date:  2005-10       Impact factor: 7.329

Review 3.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

4.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

5.  The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).

Authors:  Krzysztof C Lewandowski; Agata Cajdler-Łuba; Ireneusz Salata; Małgorzata Bieńkiewicz; Andrzej Lewiński
Journal:  Endokrynol Pol       Date:  2011       Impact factor: 1.582

6.  Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).

Authors:  Amanda Hurliman; Jennifer Keller Brown; Nicole Maille; Maurizio Mandala; Peter Casson; George Osol
Journal:  Endocrinology       Date:  2015-08-31       Impact factor: 4.736

7.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 8.  Very small embryonic-like stem cells: implications in reproductive biology.

Authors:  Deepa Bhartiya; Sreepoorna Unni; Seema Parte; Sandhya Anand
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

9.  A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective.

Authors:  B A Fenderson; U Zehavi; S Hakomori
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

Review 10.  Complications and challenges associated with polycystic ovary syndrome: current perspectives.

Authors:  Stefano Palomba; Susanna Santagni; Angela Falbo; Giovanni Battista La Sala
Journal:  Int J Womens Health       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.